Pharma
-
PBMs under fire for drug prices defend their worth
A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.
By Michael Gibney • May 26, 2022 -
Making moves: Inovio, Veru, MindMed and more announce key new hires
The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio.
By Karissa Waddick • May 25, 2022 -
Podcast
Woman of the Week: Ferring Pharmaceutical's Araz Raoof
Growing up in Iraqi Kurdistan, Raoof says a 'lethal combination' of books and strong women paved her way into STEM.
By Taren Grom • May 25, 2022 -
Pharmas can be 'more than medicine' by focusing on preventative care
Why pharma companies are changing their tack to become more than the products they sell.
By Michael Gibney • May 24, 2022 -
Sponsored by ClinicalMind
3 things medical communications can learn from sales training experts
Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".
May 23, 2022 -
Tracking trends in healthcare, from tech to patient care
High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.
By Taren Grom • May 20, 2022 -
Q&A
Ironwood Pharmaceuticals is charting a course to become a giant in GI
Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market.
By Karissa Waddick • May 19, 2022 -
A potential COVID-19 EUA could turn this small biotech into a household name
Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.
By Meagan Parrish • May 19, 2022 -
Profile
Jumping into pharma with big plans at a small company
SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.
By Alexandra Pecci • May 17, 2022 -
Q&A
BriOri BioTech sets the stage for the comeback of Vioxx
With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.
By Kelly Bilodeau • May 17, 2022 -
Are digital DCTs the answer for rare diseases?
How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.
By Kim Ribbink • May 16, 2022 -
After 40 years, researchers discover new frontiers in the fight against HIV
Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.
By Karissa Waddick • May 16, 2022 -
Sponsored by GoodRx
A better approach to boosting patient engagement
GoodRx solutions help biopharma brands overcome common barriers & increase patient engagement.
May 16, 2022 -
Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees.
OpinionWhy 'soft' skills matter in the new era of leadership
Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.
By Taren Grom • May 12, 2022 -
Podcast
Woman of the Week: AiCure's Michelle Marlborough
As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.
By Taren Grom • May 11, 2022 -
In the hot pharma talent market, execs battle these recruitment misconceptions
One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.
By Meagan Parrish • May 11, 2022 -
It's time to acknowledge access as a prescribing barrier
A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs.
By Karissa Waddick • May 11, 2022 -
FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have
New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.
By Kelly Bilodeau • May 10, 2022 -
Where hope and uncertainty meet: A cutting-edge cancer developer's winding road
Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.
By Alexandra Pecci • May 9, 2022 -
Sponsored by CorEvitas
Understanding real-world data in the real world
Real-world data (RWD) and real-world evidence (RWE) are valuable across the entire pharmaceutical product lifecycle, from examining patient outcomes to supporting disease education and awareness and beyond.
By Molly Namiotka • May 9, 2022 -
Pharma's solution to the digital advertising dilemma? Storytelling
Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.
By Karissa Waddick • May 5, 2022 -
National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.
Ultra-sensitive tests bring biomarkers into the drug development forefront
An agreement between the biomarker assay maker Quanterix and pharma giant Eli Lilly could help discover new ways to treat Alzheimer's.
By Michael Gibney • May 5, 2022 -
Podcast
Woman of the Week: Amgen's Dr. Jane Parnes
As executive medical director, early development at Amgen, Dr. Jane Parnes has helped guide clinical research for upwards of 30 of the company’s investigational molecules, including the newly approved Tezspire for severe asthma — one of her career highlights.
By Taren Grom • May 4, 2022 -
Profile
Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine
After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.
By Taren Grom , Karissa Waddick • May 4, 2022 -
Profile
Bayer executive makes strides toward a finish line for rare cancers
Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.
By Alexandra Pecci • May 3, 2022